Cargando…
Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0–1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database
BACKGROUND: The benefit of adjuvant chemotherapy in invasive lobular carcinoma (ILC) is still unclear. The objective of the current study was to elucidate the effectiveness of adjuvant chemotherapy in hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, pT1b-c/N0...
Autores principales: | Hu, Guangfu, Hu, Guangxia, Zhang, Chengjiao, Lin, Xiaoyan, Shan, Ming, Yu, Yanmin, Lu, Yongwei, Niu, Ruijie, Ye, Hui, Wang, Cheng, Xu, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035707/ https://www.ncbi.nlm.nih.gov/pubmed/32085753 http://dx.doi.org/10.1186/s12885-020-6614-0 |
Ejemplares similares
-
Adjuvant chemotherapy guidance for pT1–3N0–1 breast cancer patients with HR(+), HER2(−) subtype: a cohort study based on the SEER database
por: Wen, Nan, et al.
Publicado: (2021) -
Treatment and survival outcomes of lobular carcinoma in situ of the breast: a SEER population based study
por: Cheng, Pu, et al.
Publicado: (2017) -
Partial versus radical nephrectomy for T1b-2N0M0 renal tumors: A propensity score matching study based on the SEER database
por: Zhang, Mengping, et al.
Publicado: (2018) -
Impact of adjuvant chemotherapy on T1N0M0 breast cancer patients: a propensity score matching study based on SEER database and external cohort
por: Shen, Kaiwen, et al.
Publicado: (2022) -
Survival benefit of perioperative chemotherapy for T1–3N0M0 stage esophageal cancer: a SEER database analysis
por: Shao, Yue, et al.
Publicado: (2021)